Have your own idea? Try our Stock Screener
Finnish (OMX) Healthcare Sector Analysis
UpdatedDec 24, 2025
DataAggregated Company Financials
Companies14
- 7D2.7%
- 3M-4.8%
- 1Y31.0%
- YTD26.5%
Over the last 7 days, the Healthcare industry has risen 2.2%, driven by gains from Orion Oyj of 3.0%. This means that the industry has gained 30% over the past year. Earnings are forecast to grow by 16% annually.
Sector Valuation and Performance
Has the Finnish Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 24 Dec 2025 | €11.9b | €5.6b | €367.7m | 23.5x | 32.4x | 2.1x |
| Fri, 21 Nov 2025 | €11.3b | €5.6b | €367.7m | 21.7x | 30.8x | 2x |
| Sun, 19 Oct 2025 | €12.6b | €5.7b | €419.6m | 20.2x | 30x | 2.2x |
| Tue, 16 Sep 2025 | €12.5b | €5.7b | €420.9m | 18.7x | 29.6x | 2.2x |
| Thu, 14 Aug 2025 | €12.6b | €5.7b | €426.3m | 20.3x | 29.6x | 2.2x |
| Sat, 12 Jul 2025 | €12.9b | €5.5b | €392.7m | 18.5x | 32.9x | 2.3x |
| Mon, 09 Jun 2025 | €12.2b | €5.5b | €392.7m | 18.6x | 31.1x | 2.2x |
| Wed, 07 May 2025 | €11.4b | €5.5b | €391.6m | 19.4x | 29.2x | 2.1x |
| Fri, 04 Apr 2025 | €11.0b | €5.4b | €364.7m | 20.3x | 30.2x | 2x |
| Sun, 02 Mar 2025 | €10.9b | €5.4b | €374.8m | 20.2x | 29x | 2x |
| Tue, 28 Jan 2025 | €10.5b | €5.2b | €274.3m | 24.1x | 38.2x | 2x |
| Thu, 26 Dec 2024 | €9.0b | €5.2b | €274.3m | 19.8x | 32.9x | 1.7x |
| Sat, 23 Nov 2024 | €9.4b | €5.2b | €274.3m | 20.2x | 34.2x | 1.8x |
| Mon, 21 Oct 2024 | €10.0b | €5.0b | €145.3m | 25.4x | 68.6x | 2x |
| Wed, 18 Sep 2024 | €9.8b | €5.0b | €143.6m | 24.7x | 68.5x | 2x |
| Fri, 16 Aug 2024 | €9.8b | €5.0b | €141.7m | 28x | 68.9x | 2x |
| Sun, 14 Jul 2024 | €8.9b | €4.9b | €115.7m | 27.2x | 76.5x | 1.8x |
| Tue, 11 Jun 2024 | €8.5b | €4.9b | €115.7m | 28.6x | 73.2x | 1.7x |
| Thu, 09 May 2024 | €8.0b | €4.9b | €118.1m | 27.2x | 67.4x | 1.6x |
| Sat, 06 Apr 2024 | €7.3b | €4.8b | €108.0m | 30.6x | 67.7x | 1.5x |
| Mon, 04 Mar 2024 | €7.7b | €4.8b | €108.2m | 27.7x | 71.3x | 1.6x |
| Wed, 31 Jan 2024 | €8.7b | €4.8b | €135.4m | 34x | 64.5x | 1.8x |
| Fri, 29 Dec 2023 | €8.1b | €4.8b | €135.4m | 31.9x | 59.6x | 1.7x |
| Sun, 26 Nov 2023 | €7.7b | €4.8b | €135.4m | 30.3x | 56.6x | 1.6x |
| Tue, 24 Oct 2023 | €7.5b | €5.0b | €270.4m | 27.1x | 27.7x | 1.5x |
| Thu, 21 Sep 2023 | €7.7b | €5.0b | €269.6m | 28.4x | 28.5x | 1.5x |
| Sat, 19 Aug 2023 | €7.3b | €5.0b | €276.3m | 23.1x | 26.2x | 1.5x |
| Mon, 17 Jul 2023 | €8.0b | €5.0b | €315.2m | 38.7x | 25.3x | 1.6x |
| Wed, 14 Jun 2023 | €8.7b | €5.0b | €315.2m | 42.9x | 27.7x | 1.7x |
| Fri, 12 May 2023 | €9.0b | €5.0b | €314.4m | 44.3x | 28.6x | 1.8x |
| Sun, 09 Apr 2023 | €9.1b | €5.0b | €343.2m | 38x | 26.6x | 1.8x |
| Tue, 07 Mar 2023 | €9.2b | €5.0b | €332.6m | 37.7x | 27.8x | 1.9x |
| Thu, 02 Feb 2023 | €10.0b | €5.3b | €373.8m | 19.6x | 26.8x | 1.9x |
| Sat, 31 Dec 2022 | €10.4b | €5.3b | €373.8m | 18.6x | 27.9x | 2x |
Price to Earnings Ratio
27.9x
Current Industry PE
- Investors are pessimistic on the Finnish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 32.1x which is lower than its 3-year average PE of 42.2x.
- The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.1x.
Past Earnings Growth
- Both revenue and earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.
Industry Trends
Which industries have driven the changes within the Finnish Healthcare sector?
| FI Market | 2.05% | |
| Healthcare | 2.72% | |
| Life Sciences | 5.56% | |
| Healthtech | 3.56% | |
| Pharma | 3.22% | |
| Healthcare Services | 2.67% | |
| Biotech | 0% | 0 |
| Medical Equipment | -2.27% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 215x.
- Analysts are expecting annual earnings growth of 30.0%, which is higher than its past year's earnings growth of 17.1% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 39% over the next 5 years.
- In contrast, the Pharma industry is expected to see its earnings grow by 13% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ORNBV Orion Oyj | €63.55 | 3.2% +€281.4m | 49.7% | PE28.5x | |
| TTALO Terveystalo Oyj | €9.63 | 2.9% +€34.2m | -6.9% | PE13.4x | |
| ORIOLA Oriola Oyj | €1.14 | 5.2% +€10.4m | 28.3% | PS0.1x | |
| NANOFH Nanoform Finland Oyj | €1.14 | 5.6% +€5.1m | -7.3% | PS25.4x | |
| AIFORIA Aiforia Technologies Oyj | €2.33 | 3.6% +€2.7m | -32.9% | PS27.2x |
